X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (25) 25
female (21) 21
male (19) 19
aged (16) 16
oncology (16) 16
middle aged (15) 15
cancer (14) 14
chemotherapy (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
clinical trials (10) 10
treatment outcome (10) 10
deoxycytidine - administration & dosage (9) 9
deoxycytidine - analogs & derivatives (9) 9
hematology, oncology and palliative medicine (9) 9
adult (7) 7
analysis (7) 7
cisplatin - administration & dosage (7) 7
hospitals (7) 7
survival (7) 7
abridged index medicus (6) 6
aged, 80 and over (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cetuximab (6) 6
disease-free survival (6) 6
gemcitabine (6) 6
kaplan-meier estimate (6) 6
surgery (6) 6
capecitabine (5) 5
care and treatment (5) 5
cisplatin (5) 5
fluorouracil - administration & dosage (5) 5
mortality (5) 5
neoplasm staging (5) 5
product development (5) 5
prognosis (5) 5
quality of life (5) 5
research (5) 5
usage (5) 5
adenocarcinoma (4) 4
adenocarcinoma - pathology (4) 4
adenocarcinoma - therapy (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
chemoradiotherapy (4) 4
colorectal cancer (4) 4
esophageal neoplasms - therapy (4) 4
fluorouracil - analogs & derivatives (4) 4
journal article (4) 4
multicenter (4) 4
pancreatic cancer (4) 4
quality-of-life (4) 4
risk factors (4) 4
survival rate (4) 4
therapy (4) 4
united kingdom (4) 4
1st-line treatment (3) 3
adenocarcinoma - drug therapy (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
article (3) 3
articles (3) 3
biliary tract cancer (3) 3
biliary tract neoplasms - drug therapy (3) 3
biliary tract neoplasms - mortality (3) 3
cancer research (3) 3
cancer therapies (3) 3
capecitabine - administration & dosage (3) 3
carcinoma, squamous cell - therapy (3) 3
cardiothoracic surgery (3) 3
chemoradiation (3) 3
clinical trial, phase ii (3) 3
combined modality therapy (3) 3
digestive system diseases (3) 3
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (3) 3
dk/atira/pure/researchoutput/pubmedpublicationtype/d016449 (3) 3
dk/atira/pure/researchoutput/pubmedpublicationtype/d017427 (3) 3
dosage and administration (3) 3
drug therapy (3) 3
fluorouracil - adverse effects (3) 3
follow-up studies (3) 3
health aspects (3) 3
medical treatment (3) 3
medicine, general & internal (3) 3
metastasis (3) 3
metastatic colorectal-cancer (3) 3
multicenter study (3) 3
neoplasms (3) 3
nuclear radiation (3) 3
oncology, experimental (3) 3
organoplatinum compounds - administration & dosage (3) 3
pancreatic neoplasms - pathology (3) 3
proportional hazards models (3) 3
radiation (3) 3
radiology, nuclear medicine & medical imaging (3) 3
randomized controlled trial (3) 3
research support, non-u.s. gov't (3) 3
studies (3) 3
5-fluorouracil (2) 2
adenocarcinoma - mortality (2) 2
adjuvant treatment (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9783, pp. 2103 - 2114
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 317 - 326
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 627 - 637
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2011, Volume 142, Issue 4, pp. 776 - 782.e3
Objectives Aortic valve replacement is accepted as a standard treatment for aortic stenosis and regurgitation. To help plan the national requirement for... 
Cardiothoracic Surgery | SURVIVAL | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | OPERATIVE RISKS | FOLLOW-UP | OCTOGENARIANS | REPLACEMENT | IMPLANTATION | RESPIRATORY SYSTEM | PERICARDIAL BIOPROSTHESIS | PROSTHESIS | AGE | Heart Valve Prosthesis - utilization | Heart Valve Prosthesis Implantation - instrumentation | Age Factors | Humans | Middle Aged | Male | Prosthesis Design | Coronary Artery Bypass - utilization | Aortic Valve Stenosis - mortality | Patient Selection | Practice Patterns, Physicians' - statistics & numerical data | Time Factors | Bioprosthesis - utilization | Aged, 80 and over | Female | Aortic Valve Stenosis - surgery | Societies, Medical - statistics & numerical data | Hospital Mortality | Risk Assessment | Risk Factors | Heart Valve Prosthesis Implantation - mortality | Ireland - epidemiology | Linear Models | Logistic Models | Treatment Outcome | Chi-Square Distribution | Quality Indicators, Health Care - statistics & numerical data | Databases as Topic | Outcome and Process Assessment (Health Care) - statistics & numerical data | Heart Valve Prosthesis Implantation - adverse effects | Aortic Valve Insufficiency - surgery | Aged | Aortic Valve Insufficiency - mortality | Heart Valve Prosthesis Implantation - utilization | United Kingdom - epidemiology | Databases | Coronary artery bypass | Analysis | Aortic valve stenosis | Societies | Associations, institutions, etc | Cardiology | Statistics
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 4, pp. 810 - 818
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Life Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 967 - 978
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 601 - 611
Journal Article
Journal Article
by Abbosh, Christopher and Birkbak, Nicolai J and Wilson, Gareth A and Jamal-Hanjani, Mariam and Constantin, Tudor and Salari, Raheleh and Le Quesne, John and Moore, David A and Veeriah, Selvaraju and Rosenthal, Rachel and Marafioti, Teresa and Kirkizlar, Eser and Watkins, Thomas B. K and McGranahan, Nicholas and Ward, Sophia and Martinson, Luke and Riley, Joan and Fraioli, Francesco and Al Bakir, Maise and Grönroos, Eva and Zambrana, Francisco and Endozo, Raymondo and Bi, Wenya Linda and Fennessy, Fiona M and Sponer, Nicole and Johnson, Diana and Laycock, Joanne and Shafi, Seema and Czyzewska-Khan, Justyna and Rowan, Andrew and Chambers, Tim and Matthews, Nik and Turajlic, Samra and Hiley, Crispin and Lee, Siow Ming and Forster, Martin D and Ahmad, Tanya and Falzon, Mary and Borg, Elaine and Lawrence, David and Hayward, Martin and Kolvekar, Shyam and Panagiotopoulos, Nikolaos and Janes, Sam M and Thakrar, Ricky and Ahmed, Asia and Blackhall, Fiona and Summers, Yvonne and Hafez, Dina and Naik, Ashwini and Ganguly, Apratim and Kareht, Stephanie and Shah, Rajesh and Joseph, Leena and Quinn, Anne Marie and Crosbie, Phil A and Naidu, Babu and Middleton, Gary and Langman, Gerald and Trotter, Simon and Nicolson, Marianne and Remmen, Hardy and Kerr, Keith and Chetty, Mahendran and Gomersall, Lesley and Fennell, Dean A and Nakas, Apostolos and Rathinam, Sridhar and Anand, Girija and Khan, Sajid and Russell, Peter and Ezhil, Veni and Ismail, Babikir and Irvin-Sellers, Melanie and Prakash, Vineet and Lester, Jason F and Kornaszewska, Malgorzata and Attanoos, Richard and Adams, Haydn and Davies, Helen and Oukrif, Dahmane and Akarca, Ayse U and Hartley, John A and Lowe, Helen L and Lock, Sara and Iles, Natasha and Bell, Harriet and Ngai, Yenting and Elgar, Greg and Szallasi, Zoltan and Schwarz, Roland F and Herrero, Javier and Stewart, Aengus and Quezada, Sergio A and Peggs, Karl S and Van Loo, Peter and Dive, Caroline and Lin, C. Jimmy and Rabinowitz, Matthew and Aerts, Hugo J. W. L and ... and TRACERx Consortium and The PEACE Consortium and TRACERx consortium and PEACE consortium and The PEACE consortium and The TRACERx consortium
Nature, ISSN 0028-0836, 04/2017, Volume 545, Issue 7655, pp. 446 - 451